纵横研报
Ticker Detail

600056.SHG

¥9.64+1.47% 中国医药 Medical Distribution
00Reports China 医疗健康
China Meheco Co Ltd
医疗健康 · 医药分销

China Meheco Group Co., Ltd. operates in pharmaceutical industry in China and internationally. The company is involved in international trade of pharmaceuticals, including pharmaceutical preparations, drug substances, intermediates, medical devices, medical consumables, Chinese medicinal materials, and extracts; and pharmaceutical commerce business. It also provides supply chain services, such as sales agency, logistics and distribution, warehousing, equipment bidding, repair and maintenance, clinical value promotion, department planning, design, co-construction, operation and maintenance, SPD, and other services for various areas comprising vascular interventional therapy, non-interventional therapy, orthopedic implantation, neurosurgery, electrophysiology, pacemakers, extracorporeal circulation and blood purification, ophthalmology, and stomatology. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular and cerebrovascular, hormones and endocrine regulation, respiratory and digestive systems, nutritional supplements, antipyretic and analgesics, and other therapeutic areas, as well as Chinese herbal materials and prepared slices. The company was founded in 1983 and is based in Beijing, China.

MARKET 市值 14.30B CNY PE 29.9x 52W ¥8.3 – ¥12.48 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY -4.0% ROE 4.7% 营业利润率 4.0% 净利润率 1.4%
ANALYST 股息率 1.01%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制